Texas A&M Chemist Quentin Michaudel Earns Coveted NIH Research Award

Nov 23, 2020
“There is a constant need to invent new methods allowing for selective modifications of complex molecules, including peptides, carbohydrates and other natural products. Once a drug candidate is nominated, chemists need to devise a scalable process route that meets cost, safety and FDA requirements, which is another opportunity for chemical innovation. Some pharmaceuticals might have poor physical properties and/or stability, which might necessitate the development of polymeric drug-delivery systems to fully achieve their potential. These intricate macromolecules represent another type of synthetic challenge since they are designed to release their cargo upon external stimulation, for example, via a subtle pH or temperature change."
Dr. Quentin Michaudel, Texas A&M chemist